IOP ED denied as experimental or investigational by Aetna?

Aetna's specific coverage criteria for iop ed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Deny IOP for Eating Disorders as "Experimental"

An "experimental or investigational" denial for an Intensive Outpatient Program (IOP) designed to treat eating disorders is highly unusual — IOP is a well-established, mainstream level of care for eating disorders recognized by major professional organizations including the American Psychiatric Association (APA) and the Academy for Eating Disorders. When this denial occurs, it often means either (a) the claim coding did not clearly identify the service as a standard IOP, (b) Aetna applied its experimental criteria to a specific program component or treatment modality within the IOP (such as a newer evidence-based protocol), or (c) the denial represents an incorrect application of Aetna's coverage criteria.

## Why This Denial Is Appealable

IOP for eating disorders has a robust evidence base and is included in nationally recognized clinical practice guidelines. An experimental denial that conflicts with established clinical consensus is one of the most defensible on external review, because independent reviewers apply the standard of "generally accepted medical standards" — which IOP for eating disorders clearly meets. MHPAEA also prohibits applying experimental exclusions to behavioral health benefits more broadly than to analogous medical/surgical benefits.

## Federal Appeal Framework

• Internal appeal: Request Aetna's written clinical rationale and the specific criteria used to classify the service as experimental. File your appeal within the deadline on your denial notice.
• External review: Under ACA §2719, you have approximately four months from a final internal denial to request an independent IRO review. Experimental-designation denials are among the most commonly reversed on external review when professional guideline support is documented.
• Expedited review: If medical or psychiatric instability makes delay dangerous, request expedited review. Decisions are typically required within 72 hours.
• MHPAEA complaint: Consider filing a simultaneous complaint with your state insurance department if you believe the experimental designation is being applied more broadly to eating disorder care than to comparable medical conditions.

## Documentation to Gather

1. Clinical guideline support: A statement from your treating clinician or the IOP program citing that the treatment approach is consistent with the relevant professional organization's guidelines (e.g., the applicable APA, AED, or ASAM guideline) — without reciting specific numbers or statistics. 2. Program description and credentials: The IOP program's description of services, clinical staff credentials, and accreditation status (e.g., The Joint Commission, CARF). 3. Diagnosis and clinical necessity: Chart notes documenting your diagnosis, severity, and why this level of care is clinically appropriate rather than experimental. 4. Aetna's clinical policy: Obtain Aetna's current clinical policy bulletin for IOP and for experimental/investigational exclusions and address each criterion directly.

## Criteria-Mapping Structure

For each criterion Aetna used to classify the treatment as experimental, provide a direct rebuttal using published guideline organization names, program credentials, and your clinical documentation. Do not cite specific statistics — instead, reference the relevant guideline's existence and your program's alignment with its framework.